Eisler Capital (UK)’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,401
Closed -$384K 124
2024
Q1
$384K Sell
4,401
-8,183
-65% -$715K ﹤0.01% 235
2023
Q4
$1.21M Buy
+12,584
New +$1.21M 0.01% 161